Financials in USD. Standardized financial statements.
A compact view of how American Oncology Network, Inc. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Revenue? | $1.76B | $1.28B | $1.15B | $943.75M | $724.74M |
| Revenue Growth? | +37.5% | +11.3% | +21.8% | +30.2% | 0.0% |
| Cost of Revenue? | $1.64B | $1.20B | $1.05B | $865.79M | $658.64M |
| Gross Profit? | $117.85M | $82.80M | $95.45M | $77.96M | $66.11M |
| Gross Margin? | +6.7% | +6.5% | +8.3% | +8.3% | +9.1% |
| Operating Expenses? | $135.28M | $131.95M | $89.89M | $77.05M | $44.03M |
| Operating Income? | -$17.43M | -$49.15M | $5.57M | $911,000 | $22.07M |
| EBITDA? | $1.81M | -$39.35M | $23.09M | $7.85M | $25.94M |
| Income Before Tax | -$24.46M | -$62.51M | $2.59M | $355,000 | $21.17M |
| Income Tax Expense | $2.50M | $384,000 | $0 | $460,000 | -$783,000 |
| Net Income? | -$3.97M | -$5.54M | $2.59M | -$105,000 | $21.95M |
| EPS? | $-0.69 | $-1.36 | $0.06 | $-0.00 | $0.74 |
| Diluted EPS? | $-0.69 | $-1.36 | $0.06 | $-0.00 | $0.74 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality